CD4 and infection: Thus, the increased frequency of CD4 CTLs observed after the challenge in our immunized/challenged pigs may play a crucial role in combating de novo infection with virulent ASFV, potentially through CD4 CTL-mediated killing of infected APCs, such as monocyte/macrophages, which are primary target cells for ASFV.